Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation

被引：45

作者：

Helft, Paul R. ^{[1
]}

Daugherty, Christopher K.

机构：

[1] Indiana Univ, Sch Med, Div Hematol Oncol, Dept Med, Bloomington, IN 47405 USA

[2] Indiana Univ, Ctr Bioeth, Charles Warren Fairbanks Ctr Med Eth, Ctr Canc, Bloomington, IN 47405 USA

[3] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

[4] Univ Chicago, Canc Res Ctr, Maclean Ctr Clin Med Eth, Chicago, IL 60637 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 30期

关键词：

D O I：

10.1200/JCO.2006.05.7125

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4793 / 4795

页数：3

共 7 条

[1] Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents [J].

Agulnik, Mark ;

Oza, Amit M. ;

Pond, Gregory R. ;

Siu, Lillian L. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) :4801-4807

[2] Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer [J].

Baselga, J ;

Albanell, J ;

Ruiz, A ;

Lluch, A ;

Gascón, P ;

Guillém, V ;

González, S ;

Sauleda, S ;

Marimón, I ;

Tabernero, JM ;

Koehler, MT ;

Rojo, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5323-5333

[3] Impact of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective [J].

Daugherty, CK .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1601-1617

[4]

*DEP HHS, REP NHRPAC CLAR SPEC

[5]

Dowlati A, 2001, CLIN CANCER RES, V7, P2971

[6] Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma [J].

Friedman, HS ;

Kokkinakis, DM ;

Pluda, J ;

Friedman, AH ;

Cokgor, I ;

Haglund, MM ;

Ashley, DM ;

Rich, J ;

Dolan, ME ;

Pegg, AE ;

Moschel, RC ;

McLendon, RE ;

Kerby, T ;

Herndon, JE ;

Bigner, DD ;

Schold, SC .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3570-3575

[7]

1995, PRESIDENTS ADVISORY

← 1 →